ID

27362

Description

Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977

Mots-clés

Versions (2)
  1. 09/11/2017 09/11/2017 -
  2. 26/11/2017 26/11/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

9 novembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909

Anglais

Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909

1 Formulaires  
Administrative data
Description

Administrative data

Session number
Description

Session number

Type de données

integer

Subject number
Description

Subject number

Type de données

text

Previous Clinical Trial Participation
Description

Previous Clinical Trial Participation

Date of REDUCE 4 Year Contact
Description

The REDUCE 4 Year Contact is either: a) a REDUCE 4 Year clinic visit for subjects on treatment (Visit 10), or b) a REDUCE 4 Year clinic visit for subjects in Prostate Cancer Follow-Up (Visit 10P), or c) a 4 Year phone call for subjects in Phone Follow-Up

Type de données

date

Date Investigational Product Stopped
Description

Date Investigational Product Stopped

Type de données

date

Was the subject previously diagnosed with prostate cancer during the REDUCE (ARI40006) study?
Description

previous diagnosis of prostate cancer

Type de données

text

If YES, record the date of the biopsy resulting in prostate cancer diagnosis
Description

date of the biopsy

Type de données

date

Retour au début de la page

Similar models

Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
Session number
Item
Session number
integer
Subject number
Item
Subject number
text
Item Group
Previous Clinical Trial Participation
Date of REDUCE 4 Year Contact
Item
Date of REDUCE 4 Year Contact
date
Date Investigational Product Stopped
Item
Date Investigational Product Stopped
date
Item
Was the subject previously diagnosed with prostate cancer during the REDUCE (ARI40006) study?
text
previous diagnosis of prostate cancer
Code List
Was the subject previously diagnosed with prostate cancer during the REDUCE (ARI40006) study?
CL Item
Yes (Y)
CL Item
No (N)
date of the biopsy
Item
If YES, record the date of the biopsy resulting in prostate cancer diagnosis
date
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial